Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-19

Clinical Trial Update: Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure [NA]

View source ↗

Summary

A clinical trial testing tinzaparin (low molecular weight heparin) for treating venous thrombosis and pulmonary embolism in patients with kidney failure has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tinzaparin (tinzaparin)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Venous Thrombosis, Pulmonary Embolism | NA | Status: TERMINATED